UK MARKET TALK ROUNDUP: SHARES GAINING
30th Jun 2010 11:55
Stocks on the rise in the UK today. Compiled by Dow Jones Newswires Markets Desk, [email protected] Contact us in London. +44-20-7842-9464 [email protected] 1055 GMT [Dow Jones] UBS raises AstraZeneca (AZN.LN) price target to 4100p from 3800p following the company's victory in t
Read moreMARKET TALK: UBS Raises AstraZeneca Price Target
30th Jun 2010 11:55
1055 GMT [Dow Jones] UBS raises AstraZeneca (AZN.LN) price target to 4100p from 3800p following the company's victory in the Crestor patent case. UBS had previously seen 17% of earnings at risk from the US Crestor issue, but the bank notes this risk has now subsided. UBS adds that as Crestor discoun
Read moreBroker snap: Crestor verdict removes Astra overhang
30th Jun 2010 11:43
Panmure Gordon has doffed its hat to AstraZeneca's legal eagles after the drugs giant's favourable verdict in a Delaware court on its CRESTOR patent. "The company's impressive record in intellectual property litigation continues with a win on Crestor to accompany wins on Prilosec , Pulmicort respul
Read moreMARKET TALK: Panmure Raises AstraZeneca Price Target
30th Jun 2010 10:35
0935 GMT [Dow Jones] Panmure Gordon raises AstraZeneca (AZN.LN) price target to 3600p from 3300p, saying the company's Crestor patent victory removes a significant overhang. Expects the company to prevail in any likely appeal which will be conducted by a panel of 3 expert intellectual property lawye
Read moreUK MARKET TALK ROUNDUP: SHARES GAINING
30th Jun 2010 10:35
Stocks on the rise in the UK today. Compiled by Dow Jones Newswires Markets Desk, [email protected] Contact us in London. +44-20-7842-9464 [email protected] 0935 GMT [Dow Jones] Panmure Gordon raises AstraZeneca (AZN.LN) price target to 3600p from 3300p, saying the company's Cre
Read moreAstraZeneca Buys Back 0.7M Shares At 2955P Each
30th Jun 2010 10:10
LONDON (Dow Jones)--AstraZeneca PLC (AZN.LN) said Wednesday it purchased for cancellation 700,000 ordinary shares at a price of 2955 pence per share. -Shares at 0909 GMT up 278.5 pence, or 9.4%, at 3226.0 pence. -By Iain Packham, Dow Jones Newswires; 44-20-7842-9269; [email protected]
Read moreLondon open: Steady opening for blue chips
30th Jun 2010 08:56
London has stabilised after the pounding for share prices on both sides of the Atlantic. Anglo-Swedish drugs giant AstraZeneca is the best performer after it received a favourable US ruling in its battle to keep control of the patents to its best-selling cholesterol-lowering drug Crestor. BP is a
Read moreUK MARKET TALK ROUNDUP: BROKERS COMMENTS
30th Jun 2010 07:56
Broker comments in the UK today. Compiled by Dow Jones Newswires Markets Desk, [email protected] Contact us in London. +44-20-7842-9464 [email protected] 0656 GMT [Dow Jones] AstraZeneca's (AZN.LN) Crestor patent victory has lifted a significant uncertainty says Shore Capital.
Read moreMARKET TALK: AstraZeneca Crestor Victory Removes Uncertainty
30th Jun 2010 07:56
0656 GMT [Dow Jones] AstraZeneca's (AZN.LN) Crestor patent victory has lifted a significant uncertainty says Shore Capital. Says while there may be little scope to upgrade consensus forecasts, thinks this removes a significant overhang from the AstraZeneca investment case. Thinks investors will now
Read moreMARKET TALK: Jefferies Upgrades AstraZeneca To Hold
30th Jun 2010 07:52
0652 GMT [Dow Jones] Jefferies International upgrades AstraZeneca (AZN.LN) to hold from underperform and boosts target price to 2850p from 2550p. This comes after AstraZeneca prevails in its U.S. legal challenge against numerous companies that sought to market generic versions of Crestor prior to it
Read moreUK MARKET TALK ROUNDUP: BROKERS COMMENTS
30th Jun 2010 07:52
Broker comments in the UK today. Compiled by Dow Jones Newswires Markets Desk, [email protected] Contact us in London. +44-20-7842-9464 [email protected] 0652 GMT [Dow Jones] Jefferies International upgrades AstraZeneca (AZN.LN) to hold from underperform and boosts target price
Read moreLondon pre-open: Small gains ahead
30th Jun 2010 07:36
London's top stocks are expected to open only slightly higher following yesterday's heavy losses. Traders were nervy in Europe about bank payments that need to be made to the European Central Bank this week, while triple-digit falls on Wall Street added to London's woes on Tuesday. Today, traders e
Read moreUK MARKET TALK ROUNDUP: BROKERS COMMENTS
30th Jun 2010 07:12
Broker comments in the UK today. Compiled by Dow Jones Newswires Markets Desk, [email protected] Contact us in London. +44-20-7842-9464 [email protected] 0612 GMT [Dow Jones] JPMorgan Cazenove upgrades AstraZeneca (AZN.LN) to neutral from underweight following the US Crestor pat
Read moreMARKET TALK: JPMorgan Upgrades AstraZeneca To Neutral
30th Jun 2010 07:12
0612 GMT [Dow Jones] JPMorgan Cazenove upgrades AstraZeneca (AZN.LN) to neutral from underweight following the US Crestor patent ruling in its favor. Raises its price target to 3360p from 2960p. Says while generic challengers are likely to appeal, the probability of reversing this ruling appears to
Read moreSUBSCRIBERS: AstraZeneca: Crestor Patent Upheld Already Reported
30th Jun 2010 07:08
Please disregard the headline timed 0601 GMT as this news was reported in full at 2108 GMT Tuesday. (END) Dow Jones Newswires June 30, 2010 02:08 ET (06:08 GMT)
Read more